Not applicableStudy completedNCT03145844What this trial is testingDirect Acting Agents in Hepatitis C PatientsWho this might be right forHepatitis CHepatitis C RelapseHepatitis C Recurrent Fehmi Tabak 2,700
Post-approval studies (Phase 4)Study completedNCT00993122What this trial is testingRibavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) RecipientsWho this might be right forHepatitis C University of Roma La Sapienza 100
Testing effectiveness (Phase 2)UnknownNCT01603108What this trial is testingRifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver TransplantWho this might be right forHepatitis C Columbia University 59
Large-scale testing (Phase 3)Study completedNCT01453218What this trial is testingSafety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal DysfunctionWho this might be right forRenal Insufficiency Hospital Vall d'Hebron 30
Large-scale testing (Phase 3)Ended earlyNCT02478229What this trial is testingEarly Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)Who this might be right forHepatitis C Viral Infection University Health Network, Toronto 1
Very early researchEnded earlyNCT00882193What this trial is testingPilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/RelapsersWho this might be right forChronic Hepatitis CGenotype 1Relapse University of Nebraska 2
Post-approval studies (Phase 4)Study completedNCT01134952What this trial is testingStudy of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)Who this might be right forHepatitis C London Health Sciences Centre 11
Testing effectiveness (Phase 2)Study completedNCT01938625What this trial is testingPharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver TransplantationWho this might be right forHepatitis C, Chronic Janssen R&D Ireland 35
Not applicableEnded earlyNCT00867243What this trial is testingPrediction of Hepatitis C Recurrence in Liver Transplant RecipientsWho this might be right forComplication of Transplanted LiverHepatitis C, Chronic Northwestern University 24
Large-scale testing (Phase 3)Study completedNCT01640808What this trial is testingStudy of Peretinoin for Suppressing Recurrence of HCV-positive HCCWho this might be right forHepatic Neoplasm Malignant Recurrent Kowa Company, Ltd. 616
Not applicableStudy completedNCT03707080What this trial is testingDirect Acting Antiviral-Post Authorization Safety StudyWho this might be right forHepatitis CHepatocellular Carcinoma Target PharmaSolutions, Inc. 42
Post-approval studies (Phase 4)Ended earlyNCT00641654What this trial is testingCombination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and RibavirinWho this might be right forChronic Hepatitis C Göteborg University 75
Not applicableStudy completedNCT01428700What this trial is testingGene Expression in Liver Allograft Rejection and Recurrent Hepatitis CWho this might be right forLiver Transplantation National Institute of Allergy and Infectious Diseases (NIAID) 275
Not applicableUnknownNCT04156945What this trial is testingInterventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With MenWho this might be right forHepatitis C Virus Infection Public Health Service of Amsterdam 258
Large-scale testing (Phase 3)Study completedNCT00151580What this trial is testingTreatment of Recurrent Hepatitis C After Liver TransplantationWho this might be right forLiver TransplantationHepatitis C Rennes University Hospital 200
Post-approval studies (Phase 4)Study completedNCT04653818What this trial is testingHCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled TrialWho this might be right forHepatocellular CarcinomaHepatitis CNeoplasm Recurrence+1 more Alexandria University 84
Testing effectiveness (Phase 2)Study completedNCT00695019What this trial is testingInterferon-alpha Lozenges for Prevention of Relapse in Hepatitis CWho this might be right forHepatitis C, Chronic Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 169
Large-scale testing (Phase 3)Ended earlyNCT00165633What this trial is testingA Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Eisai Limited 540
Not applicableUnknownNCT04768517What this trial is testingHCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral TherapyWho this might be right forHepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection National Taiwan University Hospital 300
Not applicableUnknownNCT04004299What this trial is testingSelf-testing for HCV Re-infection in MSMWho this might be right forHepatitis C RecurrentHIV-1-infection Erasmus Medical Center 200